A Case Series of HCV Genotype 1a Infection Patients With HIV Co-infection Treated With 8 Weeks of Ledipasvir-Sofosbuvir

被引：0
作者：
Umar, Shifa [1 ]
Hsiao, Chiu-Bin [1 ]
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-02128
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2127
引用
收藏
页码：S1179 / S1179
页数：1
相关论文
共 50 条
  • [41] Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature
    Fabbri, Gabriele
    Mastrorosa, Ilaria
    Vergori, Alessandra
    Mazzotta, Valentina
    Pinnetti, Carmela
    Grisetti, Susanna
    Zaccarelli, Mauro
    Ammassari, Adriana
    Antinori, Andrea
    [J]. BMC INFECTIOUS DISEASES, 2017, 17
  • [42] No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection
    Sulkowski, Mark S.
    Chuang, Wan-Long
    Kao, Jia-Horng
    Yang, Jenny C.
    Gao, Bing
    Brainard, Diana M.
    Han, Kwang-Hyub
    Gane, Edward
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (09) : 1202 - 1204
  • [43] Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature
    Gabriele Fabbri
    Ilaria Mastrorosa
    Alessandra Vergori
    Valentina Mazzotta
    Carmela Pinnetti
    Susanna Grisetti
    Mauro Zaccarelli
    Adriana Ammassari
    Andrea Antinori
    [J]. BMC Infectious Diseases, 17
  • [44] Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case report
    Tadokoro, Tomoko
    Morishita, Asahiro
    Oura, Kyoko
    Fujita, Koji
    Mimura, Shima
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Yoneyama, Hirohito
    Masaki, Tsutomu
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 1026 - 1028
  • [45] Retreatment of patients co-infected with HCV and HIV-1 who failed 12 weeks of ledipasvir/sofosbuvir
    Bhagani, S.
    Cooper, C.
    Naggie, S.
    Saag, M.
    Yang, J.
    Stamm, L.
    Natha, M.
    Dvory-Sobol, H.
    McHutchinson, J.
    Jackson, A.
    Dieterich, D.
    Sulkowski, M.
    [J]. HIV MEDICINE, 2016, 17 : 38 - 38
  • [46] Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection
    Yanny, Beshoy T.
    Latt, Nyan L.
    Saab, Sammy
    Han, Steven
    Choi, Gina
    Kramer, Jason
    Sahota, Amandeep K.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (10) : 908 - 912
  • [47] Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection
    Jensen, Christopher M.
    Holle, Lisa M.
    [J]. PHARMACOTHERAPY, 2016, 36 (05): : 562 - 574
  • [48] Treatment of acute HCV infection in HIV co-infection: Influence of HCV genotype and ribavirin upon treatment outcome
    Boesecke, Christoph
    Ingiliz, Patrick
    Stellbrink, Hans-Juergen
    Nelson, Mark
    Page, Emma E.
    Bhagani, Sanjay
    Guiguet, Marguerite
    Valantin, Marc-Antoine
    Reiberger, Thomas
    Vogel, Martin
    Rockstroh, Juergen K.
    [J]. HEPATOLOGY, 2012, 56 : 215A - 215A
  • [49] Ledipasvir/Sofosbuvir single tablet regimen is highly effective treatment for patients with HCV genotype 2 infection
    Gane, E. J.
    Hyland, R. H.
    Yang, Y.
    Svarovskaia, E.
    Pang, P. S.
    McHutchison, J. G.
    Stedman, C. A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 15 - 15
  • [50] Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome
    Christoph Boesecke
    Patrick Ingiliz
    Thomas Reiberger
    Hans-Jürgen Stellbrink
    Sanjay Bhagani
    Emma Page
    Stefan Mauss
    Thomas Lutz
    Esther Voigt
    Marguerite Guiguet
    Marc-Antoine Valantin
    Axel Baumgarten
    Mark Nelson
    Martin Vogel
    Jürgen K. Rockstroh
    [J]. Infection, 2016, 44 : 93 - 101
12345